Industry Insights

  1. Nanoparticle Engineering: Revolutionizing Oral Drug Delivery

    Nanoparticle engineering has emerged as a promising solution for enhancing drug solubility and bioavailability and improving efficiency within the drug development pipeline.

  2. What Happens When You Refuse To Compromise On Sustainability? 8/8/2025

    Discover how an empty building shell became a sustainable nanomedicine hub and achieved 47% energy savings and 88% fewer emissions, which sets new standards for innovation in the biologics industry.

  3. Creating A Compliant And Scalable CGT Logistics Launch Plan 6/12/2025

    As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.

  4. The 5 Pillars Of Clinical Trial Material Management 2/25/2020

    Ensuring that enough study drug supplies are available at study sites is a requirement of every clinical trial. This article discusses five fundamental tools and techniques for effective planning, execution, monitoring, and inventory control of clinical trial material from the manufacturing, packaging, and distribution perspectives.

  5. 4K Operating Room Technology Advancing, Despite Initial Doubts 8/8/2018

    As the minimally invasive approach continues to become standard procedure, demand for surgical visualization equipment will continue to rise. Continued adoption of 4k technology is bolstering growth in the total U.S. video and integrated operating room equipment market, which currently is valued at almost $2.3 billion.

  6. Breaking The Blind In Clinical Trials & Reporting To Health Authorities, Investigators & IRBs/Ethics Committees 2/12/2013

    This is a topic that has caused much consternation in pharmaceutical companies and has, in my experience, caused some clinical trials and even NDAs to fail due to an inadequate number of analyzable patients. By Bart Cobert

  7. Pitching Your Biotech To Investors 6/8/2020

    Early-stage biopharmas find themselves in an increasingly crowded field of companies seeking capital, and the noisier the crowd gets, the harder it is to differentiate your science, your people, and your value proposition. Unless you’re extremely lucky or the spouse or offspring of a billionaire, successfully producing investor dollars from the story of your science, people, and value proposition is going to require a pitch deck and tireless energy to present it. Multi-time biotech founder Leslie Williams has been down this road more than once, and she’s got plenty of candid advice on building a pitch deck and preparing for the pitching process.

  8. Application Of CRISPR Technology In iPSC Gene Correction 10/14/2025

    The CRISPR-iPSC combination is becoming a core tool for precision medicine with advanced editing efficiency, differentiation control, and safety profiles.

  9. This Digital Twin Approach Aims To Optimize ATMP Production 9/25/2024

    Manufacturing therapeutic cells includes labor-intensive processes. These researchers are developing a way to increase yields through cost-effective expansion protocols.

  10. Small Is Powerful And Sustained

    Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.